SCHEMBL19923728

SCHEMBL19923728

CN1C(=O)N([Si](C)(C)C)C(=O)C1(C)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.40
ALDH1A1 P00352 4/20 0.39
BRD4 O60885 1/20 0.38
BACE1 P56817 4/20 0.38
BACE2 Q9Y5Z0 3/20 0.38
REN P00797 1/20 0.38
APP P05067 1/20 0.38
LMNA P02545 3/20 0.38
GAA P10253 2/20 0.38
PAX8 Q06710 1/20 0.38
MCL1 Q07820 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PLA2G7 Q13093 1/20 0.35
HTR1A P08908 1/20 0.34
HTR6 P50406 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
CTSD P07339 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923472 0.84 ALDH1A1 (0.41) PKMALDH1A1BRD4BACE1BACE2
SCHEMBL19923706 0.83 ALDH1A1 (0.39) PKMALDH1A1BRD4BACE1BACE2
SCHEMBL19923549 0.83 TSHR (0.38) PKMALDH1A1BRD4BACE1BACE2
SCHEMBL19923407 0.81 TSHR (0.37) PKMALDH1A1BRD4BACE1BACE2
SCHEMBL19923735 0.81 PKM (0.41) PKMALDH1A1BACE1BACE2REN
SCHEMBL19923499 0.81 ALDH1A1 (0.37) PKMALDH1A1BRD4BACE1BACE2
SCHEMBL19923594 0.81 ALDH1A1 (0.37) PKMALDH1A1BRD4BACE1BACE2
SCHEMBL19923628 0.80 BACE1 (0.39) ALDH1A1BACE1BACE2RENAPP
SCHEMBL19923740 0.79 HTR1A (0.46) PKMALDH1A1BACE1BACE2REN
SCHEMBL19923637 0.77 ELANE (0.44) ALDH1A1LMNAGAAHTR1AHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN PKM 1356/4885ALDH1A1 2648/4885BRD4 391/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM PKM 1417/4885ALDH1A1 2554/4885BRD4 490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.